Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by qwerty22


V.FL

RE:RE:TRADE HALT

Given late last year signals seems too early for PFS but maybe I misread the...

February 28, 2023

T.TH

RE:Bit of clarity on oncology thoughts from CMO

First off you have to recognize the questions around this program have...

February 28, 2023

T.TH

RE:RE:RE:RE:RE:LinkedIn

The only thing this shows is people on this board are desperate for news!

February 27, 2023

V.FL

RE:FL got beaten down hard in one trading session for a reason

You must be financially awesome given your ability to read a single days...

February 24, 2023

T.TH

RE:Is this a game changer

Can they seek extended label for that indication in HIV patients? Nope. This...

February 23, 2023

V.RHT

RE:RE:RE:RE:RE:RE:RE:RE:CEO purchases more

I'd have thought it's staying above past bottoms because it looks a...

February 22, 2023

T.TH

RE:RE:RE:Presentation post or link?

IDK, the most optimistic take I have on that PR is that they were clearing...

February 22, 2023

T.TH

RE:RE:RE:RE:RE:Presentation post or link?

I would guess that people attending this conference wouldn't be that...

February 22, 2023

V.RHT

RE:CEO purchases more

Effectively rules out takeover nonsense.

February 21, 2023

T.TH

RE:RE:NASH is Back

"insights and learnings" can be a long way from a clinical update.

February 20, 2023

T.TH

RE:RE:RE:RE:RE:New Press Release - Theratechnologies Announces Path to Resume TH1902 Clinical Development

I think I have lower expectations than others about what is achievable in the...

February 16, 2023

T.TH

RE:RE:RE:RE:New Press Release - Theratechnologies Announces Path to Resume TH1902 Clinical Development

There was no time when they weren't considering patient selection...

February 16, 2023

T.TH

RE:RE:RE:New Press Release - Theratechnologies Announces Path to Resume TH1902 Clinical Development

"Once the Phase 1 clinical trial has resumed" SPCEO, are you...

February 16, 2023

T.TH

RE:RE:RE:RE:RE:RE:Posted on LinkedIn

I don't think they can find the answers you are looking for in the blood,...

February 15, 2023

V.FL

RE:PMET hi 17.40 x 132.35 million shares fully diluted

I'll happily sell you all my stock today based on your formula for...

February 15, 2023

V.FL

RE:My target is 2.5 billion US $ MC .

BTW you are allowing yourself an awfully large rounding up if you think PMET...

February 15, 2023

V.FL

RE:My target is 2.5 billion US $ MC .

PMET  is falling. It's overheated valuation still looks...

February 15, 2023

T.TH

RE:RE:Posted on LinkedIn

Seems to me more like these answers are completely ignoring the reality of...

February 15, 2023

V.FL

RE:Possibilities...

The company is far stronger now than when they hit $4 mid-22.

February 9, 2023

T.TH

RE:RE:TH at the Next Gen Conjugates Conference

It's very difficult to see what's going to happen with this...

February 7, 2023

Featured Company